Abstract: The present invention describes novel plant derived elastin-like peptides and peptidomimetics that may serve as functional ligands for elastin receptors and stimulate elastogenesis. The novel plant derived peptides provide an alternative (non-animal derived) source of GXXPG (SEQ ID NO. 2) containing peptides. The present invention also describes therapeutic compositions containing novel plant derived peptides or peptidomimetics useful in stimulating elastogenensis and capillary dilatation. The therapeutic compositions of the present invention that comprise novel plant derived peptides or peptidomimetics may be combined with other therapeutic agents.
Type:
Application
Filed:
October 15, 2020
Publication date:
September 9, 2021
Applicants:
ELASTOGENESIS, LLC, THE HOSPITAL FOR SICK CHILDREN
Inventors:
Felipe JIMENEZ, Thomas MITTS, Aleksander HINEK
Abstract: The present invention describes novel plant derived elastin-like peptides and peptidomimetics that may serve as functional ligands for elastin receptors and stimulate elastogenesis. The novel plant derived peptides provide an alternative (non-animal derived) source of GXXPG (SEQ ID NO. 2) containing peptides. The present invention also describes therapeutic compositions containing novel plant derived peptides or peptidomimetics useful in stimulating elastogenensis and capillary dilatation. The therapeutic compositions of the present invention that comprise novel plant derived peptides or peptidomimetics may be combined with other therapeutic agents.
Type:
Grant
Filed:
November 27, 2018
Date of Patent:
November 24, 2020
Assignees:
Elastogenesis, LLC, The Hospital for Sick Children
Inventors:
Felipe Jimenez, Thomas Mitts, Aleksander Hinek